Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 22, 2019

Primary Completion Date

April 2, 2020

Study Completion Date

April 2, 2020

Conditions

Diabetes Mellitus, Type 1Insulin-dependent Diabetes Mellitus

Interventions

DRUG

PRAM9

SC injection

DRUG

Regular Insulin + Pramlintide

Separate SC injections

DRUG

Regular Insulin

SC injection

Trial Locations (1)

World Wide Clinical Trials, San Antonio